Study of miRNA146a as a downregulator of CXCR₄ expression in acute myeloid leukemias / Nouran Mohamed Nabil Momen ; Supervised Hanaa Hamed Arnaout , Mona Salah Eldin Hamdy , Manal Michel Wilson
Material type:
- فى سرطانات الدم النخاعى الحاد CXCR4 باعتباره مهبط لل miRNA146a دراسة ال [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.07.Ph.D.2015.No.S (Browse shelf(Opens below)) | Not for loan | 01010110069261000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.07.Ph.D.2015.No.S (Browse shelf(Opens below)) | 69261.CD | Not for loan | 01020110069261000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology
CXCR4 / CXCL12 interaction plays an important role in both homing and retention of hematopoietic stem cells in the bone marrow. Leukemic cells express high levels of CXCR4, and this pathway plays a critical role in their migration into the bone marrow which supports their growth and survival. Antagonism of CXCR4 mobilizes stem cells into the bloodstream e.g. by AMD3100. MiRNA146a is one of the miRNAs most downmodulated in AML blasts. A highly significant inverse correlation between miR-146a expression and CXCR4 membrane protein level was found. Thus, upregulation of MiRNA146 may lead to down regulation of the CXCR4 protein levels and this relation may be used as a therapeutic modality. Thirty six denovo AML cases were selected. MiRNA146-a gene expression by real time PCR quantitation in leukemic cells before and after stimulation with vitamin D3 and AMD3100 was performed. Immunophenotypic characterization of surface and cytoplasmic expression of CXCR4 of isolated leukemic cells. Twenty four-hour stimulation with Vitamin D3 and AMD3100 was done followed by reestimation of surface and cytoplasmic expression of CXCR4. Cells were also cultured in special in vitro cell migration assay wells to detect effect of Vit D3 and AMD3100 on cell migration. AMD3100 increased miR146a expression which in turn downmodulated CXCR4 expression. Vit D3 also increased miRNA expression but less significantly. There was no statistically significant difference between effects of AMD3100 and Vit D3 on CXCR4 expression and cell migration. These findings suggest that Vit D3 may be considered as an alternative to AMD3100. Further research will indicate whether Vit D3 can be used as an adjuvant therapy to increase mobilization of leukemic stem cells from the bone marrow and improve response to chemotherapy
Issued also as CD
There are no comments on this title.